Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christiane Engelbertz

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
European Heart Journal|February 8, 2022
Sex-related differences in treatment and outcome of chronic limb-threatening ischaemia: a real-world cohortLena Makowski, Jeanette Köppe, Christiane Engelbertz, et al.
Atherosclerosis|May 28, 2023
Sex disparities in guideline-recommended therapies and outcomes after ST-elevation myocardial infarction in a contemporary nationwide cohort of patients over an eight-year periodLeonie Kuehnemund, Stefan A Lange, Jannik Feld, et al.
Circulation|November 6, 2022
A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 StudyHolger Reinecke, Christiane Engelbertz, Rupert Bauersachs, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
European Heart Journal|February 8, 2022
Sex-related differences in treatment and outcome of chronic limb-threatening ischaemia: a real-world cohortLena Makowski, Jeanette Köppe, Christiane Engelbertz, et al.
Atherosclerosis|May 28, 2023
Sex disparities in guideline-recommended therapies and outcomes after ST-elevation myocardial infarction in a contemporary nationwide cohort of patients over an eight-year periodLeonie Kuehnemund, Stefan A Lange, Jannik Feld, et al.
Circulation|November 6, 2022
A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 StudyHolger Reinecke, Christiane Engelbertz, Rupert Bauersachs, et al.
Pageof 5